Source: FierceBiotech

The Medicines Company: News of Note-Novartis backs out of Akcea/Ionis research deal; Flagship jumps on gene therapy bandwagon

Welcome to our pre-Christmas news of note, as we gather up bite-size news from around biotech.

Read full article »
The Medicines Company's Competitors | The Medicines Company's News | The Medicines Company's Financials
Stay up-to-date with the latest news on The Medicines Company
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark Timney's photo - CEO of The Medicines Company

CEO

Mark Timney

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on The Medicines Company